Antibiotic resistance is a leading health threat, and whole genome sequencing is the most accurate way to study pathogens. We make it easier to understand, detect and prevent the spread of antibiotic resistance.
Employees: 1-10
Total raised: $1.095106M
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 16.06.2023 | - | $1.095106M | - | tech.eu/20... |
Mentions in press and media 4
| Date | Title | Description | Source |
| 16.06.2023 | Finland's Solu raises €1 million, partners with Stanford and... | Finnish biotech start-up Solu has raised €1 million in funding to fuel the development and commercia... | tech.eu/20... |
| 15.06.2023 | Finnish biotech Solu raises €1M to deal with antibiotic resi... | Finnish biotech Solu raises €1M to deal with antibiotic resistance 15 June, 2023, 11:34 Rostyslav ... | ain.capita... |
| 15.06.2023 | Solu Raises €1M in Funding | Solu, a Helsinki, Finland-based biotechnology company focusing on combating antibiotic resistance, r... | finsmes.co... |
| - | Solu | “Discover the next generation toolkit for analyzing, storing and sharing bacterial genomes.” | fastfounde... |